Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
Status:
Not yet recruiting
Trial end date:
2023-10-30
Target enrollment:
Participant gender:
Summary
This is a single center, randomized, controlled study, to evaluate the efficacy and safety of
Herombopag in patients with Thrombocytopenia before hepatectomy.